Fetal nuchal translucency scan in Nigeria
- PMID: 26113896
- PMCID: PMC4473784
- DOI: 10.11604/pamj.2014.18.62.3291
Fetal nuchal translucency scan in Nigeria
Abstract
Introduction: To evaluate the performance of first trimester nuchal translucency scan screening among pregnant women in Nigeria.
Methods: A prospective observational and questionnaire based study involving 510 pregnant women between 11(+0) and 13(+6) weeks. Routine counselling and nuchal translucency measurement was conducted using the FMF, London guidelines. Chorionic villous sampling was done at NT ≥ 2.5 mm or ≥ 95th centile.
Results: Five hundred and ten out of 542 (94.1%) were analysed, mainly referred by health care workers (87.2%) and from predominantly private facilities (94.3%). The number of NT scans performed increased in successive years with corresponding decrease in the mean scanning time. Scan was successfully completed at first attempt in (96.5%), with mean scanning time of 28.3 minutes. Nuchal translucency increases with gestational but not maternal age. The median and 95th centile at 11(+0) week was 1.2mm and 1.7 mm and at 13(+6) weeks was 1.5 mm and 2.2 mm. Using a cut-off of ≥ 2.5 mm or ≥ 95th centile, 17 (3.3%) screened positive. Three out of the 17 had invasive testing and 2 (DR = 66.7%) were confirmed trisomy 21, with a false positive rate of 5.9%. Although majority (86.4%) were willing to have invasive testing, only few (3 or 17.6%) of the high risk group had testing.
Conclusion: The study demonstrated that NT scan is feasible as a screening tool in pregnancy in Nigeria. Measures of improving utilization include wider dissemination of information, provision of dedicated NT clinics and manpower training.
Keywords: Down syndrome; Nuchal translucency scan; Performance.
Figures
Similar articles
-
Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.Fetal Diagn Ther. 2006;21(3):264-8. doi: 10.1159/000091353. Fetal Diagn Ther. 2006. PMID: 16601335
-
If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.Acta Obstet Gynecol Scand. 2006;85(5):534-8. doi: 10.1080/00016340500523701. Acta Obstet Gynecol Scand. 2006. PMID: 16752230
-
Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.Srp Arh Celok Lek. 2012 Sep-Oct;140(9-10):606-11. Srp Arh Celok Lek. 2012. PMID: 23289277
-
[First trimester screening for Down syndrome: five years prospective experience].J Gynecol Obstet Biol Reprod (Paris). 2010 Sep;39(5):353-61. doi: 10.1016/j.jgyn.2010.04.007. Epub 2010 Jun 11. J Gynecol Obstet Biol Reprod (Paris). 2010. PMID: 20541874 Review. French.
-
Screening for fetal aneuploidies at 11 to 13 weeks.Prenat Diagn. 2011 Jan;31(1):7-15. doi: 10.1002/pd.2637. Prenat Diagn. 2011. PMID: 21210475 Review.
Cited by
-
Breaking Bad News During Prenatal Screening: The Role of Professional Obstetricians and Midwives in Greece.Cureus. 2024 Mar 23;16(3):e56787. doi: 10.7759/cureus.56787. eCollection 2024 Mar. Cureus. 2024. PMID: 38650784 Free PMC article.
-
Prevalence and diagnostic dilemma of chromosomal abnormalities in the Niger Delta area of Nigeria; Is prenatal diagnosis worthwhile?Niger Med J. 2025 Apr 3;66(1):60-69. doi: 10.71480/nmj.v66i1.561. eCollection 2025 Jan-Feb. Niger Med J. 2025. PMID: 40309537 Free PMC article.
-
Prenatal Ultrasound Screening and Women's Expectations: an Original Study.Mater Sociomed. 2022 Jun;34(2):136-141. doi: 10.5455/msm.2022.34.136-141. Mater Sociomed. 2022. PMID: 36199849 Free PMC article.
References
-
- Nicolaides KH, Brizot ML, Snidjers RJM. Fetal nuchal translucency: Ultrasound screening for fetal trisomy in first trimester of pregnancy. Br J Obstet Gynecol. 1994;101(9):782–6. - PubMed
-
- Pandya PP, Brizot ML, Kuhn P, Snijders RJ, Nicolaides KH. First trimester fetal nuchal translucency thickness and risk for trisomies. Obstet Gynecol. 1994;84(3):420–3. - PubMed
-
- Snidjers RJ, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10 – 14 weeks gestation. Fetal Medicine Foundation First Trimester Screening Group. Lancet. 1998;352(9125):343–6. - PubMed
-
- Pandya PP, Kondylios A, Hilbert L, Snijders RJ, Nicolaides KH. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol. 1995;5(1):15–9. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials